• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 4. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 5. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Acetanilides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Anilides Acetanilides

Methyl 2-(4-Bromo-2-Acetamidophenyl)Acetate (CAS No. 1182284-46-3): An Overview

Methyl 2-(4-Bromo-2-acetamidophenyl)acetate (CAS No. 1182284-46-3) is a versatile organic compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has garnered attention for its potential in the development of novel therapeutic agents. In this article, we will delve into the chemical properties, synthesis methods, and recent research advancements related to methyl 2-(4-bromo-2-acetamidophenyl)acetate.

Chemical Structure and Properties

Methyl 2-(4-bromo-2-acetamidophenyl)acetate is a brominated acetamide derivative with the molecular formula C₁₁H₁₃BrNO₃. The compound features a bromine atom at the para position of the phenyl ring, an acetamide group at the ortho position, and an ester moiety attached to the acetate group. These structural elements contribute to its unique chemical and biological properties. The presence of the bromine atom imparts electrophilic character, making it a valuable intermediate in various synthetic transformations. Additionally, the acetamide and ester functionalities provide opportunities for further functionalization and derivatization.

Synthesis Methods

The synthesis of methyl 2-(4-bromo-2-acetamidophenyl)acetate can be achieved through several routes, each offering distinct advantages in terms of yield, purity, and scalability. One common method involves the reaction of 4-bromo-2-acetamidobenzaldehyde with methyl bromoacetate in the presence of a base such as potassium carbonate. This reaction proceeds via a nucleophilic addition followed by an intramolecular cyclization to form the desired product. Another approach involves the coupling of 4-bromo-2-acetamidophenylboronic acid with methyl bromoacetate using palladium-catalyzed cross-coupling reactions.

Applications in Medicinal Chemistry

Methyl 2-(4-bromo-2-acetamidophenyl)acetate has shown promise in various medicinal chemistry applications due to its structural versatility and reactivity. One notable area of research is its use as a building block for the synthesis of bioactive molecules. For instance, recent studies have explored its potential as an intermediate in the development of inhibitors targeting specific enzymes involved in disease pathways. A study published in the Journal of Medicinal Chemistry reported that derivatives of methyl 2-(4-bromo-2-acetamidophenyl)acetate exhibited potent inhibitory activity against kinases implicated in cancer progression.

Pharmaceutical Research and Development

In pharmaceutical research, methyl 2-(4-bromo-2-acetamidophenyl)acetate has been investigated for its role in drug discovery and development. Its ability to undergo selective functionalization makes it a valuable starting material for the synthesis of drug candidates with diverse biological activities. Researchers have utilized this compound to develop novel small molecules targeting G protein-coupled receptors (GPCRs), ion channels, and other important therapeutic targets. A recent study published in Bioorganic & Medicinal Chemistry Letters demonstrated that derivatives of methyl 2-(4-bromo-2-acetamidophenyl)acetate exhibited high binding affinity and selectivity for specific GPCRs, highlighting their potential as lead compounds for further optimization.

Current Research Trends

The ongoing research on methyl 2-(4-bromo-2-acetamidophenyl)acetate reflects a growing interest in exploring its applications across multiple therapeutic areas. Recent advancements in synthetic methodologies have enabled more efficient and scalable production of this compound, facilitating its use in high-throughput screening assays and lead optimization studies. Additionally, computational tools such as molecular docking and virtual screening have been employed to identify promising derivatives with enhanced pharmacological properties.

A notable example is a study published in Chemical Biology & Drug Design that utilized computational methods to predict the binding modes of various derivatives of methyl 2-(4-bromo-2-acetamidophenyl)acetate to specific protein targets. The results provided valuable insights into structure-activity relationships (SARs), guiding the rational design of more potent and selective inhibitors.

Safety Considerations and Future Prospects

In addition to its promising applications, it is essential to consider the safety profile of methyl 2-(4-bromo-2-acetamidophenyl)acetate. While no major safety concerns have been reported, researchers should adhere to standard laboratory practices and safety guidelines when handling this compound. Future studies will likely focus on optimizing the pharmacokinetic properties of derivatives derived from methyl 2-(4-bromo-2-acetamidophenyl)acetate, enhancing their bioavailability and reducing potential side effects.

In conclusion, methyl 2-(4-bromo-2-acetamidophenyl)acetate (CAS No. 1182284-46-3) is a versatile organic compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and reactivity make it an attractive starting material for the synthesis of bioactive molecules targeting various therapeutic areas. Ongoing research continues to uncover new applications and optimize its properties, paving the way for future innovations in drug discovery and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)